Trading Ideas can sometimes be seen by looking at what a company insiders are doing. It is assumed they know something that we don't. So sometimes look thru this list for new ideas.NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from September 7 through September 11 include: Beneficial owner of Kodiak Sciences ($KOD) Baker Bros purchased 322,979 shares of company stock at $47.43 per share for a total transaction amount of $15,318,345 Shareholder of IGM Biosciences ($IGMS) Redmile Group purchased 144,806 shares of company stock at $50.52 per share for a total transaction amount of $7,316,019 Beneficial owner of Odonate Therapeutics ($ODT) Boxer Capital purchased 225,000 shares of company stock at $14.99 per share for a total transaction amount of $3,371,625 Director of Karuna Therapeutics ($KRTX) James Healy purchased 4,557 shares of company stock at $73.75 per share for a total transaction value of $336,079 Beneficial owner of Merus ($MRUS) BVF Partners purchased 201,906 shares of company stock at $11.17 per share for a total transaction value of $2,255,290 NOTABLE INSIDER SALES: Significant insider sales reported in the prior week from September 7 through September 11 include: Beneficial owner of Keurig Dr Pepper ($KDP) Mondelez ($MDLZ) sold 12,506,825 shares of company stock at $29.00 per share for a total transaction value of $362,697,925 CEO of Electronic Arts ($EA) Andrew Wilson sold 250,000 shares of company stock at $124.67 per share for a total transaction value of $31,166,250 Director of CrowdStrike Holdings ($CRWD) Joseph sexton sold 12,500 shares of company stock at $128.36 per share for a total transaction value of $1,604,518 COO of DexCom ($DXCM) Quentin Blackford sold 12,193 shares of company stock at $400.59 per share for a total transaction value of$4,884,343 Director of Zoom Video ($ZM) Bart Swanson sold 2,000 shares of company stock at $353.88 per share for a total transaction value of $707,750. NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTIONS: Shares of Karuna Therapeutics are up approximately 13% since director James Healy purchased shares, while shares of DexCom are down approximately 2% since COO Quentin Blackford sold shares. Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page. .Are you interested in trading stocks to supplement your income or make a living? Maybe become a professional trader? Many traders have the skills and nerves to trade, but not the upfront capital. Well now that problem is solved!Try2BeFunded has expanded its trading program! If you're a novice or experienced trader, you can earn access to a trading account with up to $100,000! To learn more about how to qualify, click HERE and give it a shot! You have nothing to lose it is free to try. Trade Try2BeFunded today! .